Integra Lifesciences Holdings (IART) Acquisitions (2009 - 2018)

Integra Lifesciences Holdings has disclosed Acquisitions across 10 years of filings, most recently posting -$53.4 million for Q4 2018.

• In Q4 2018, Acquisitions fell 105.25% year-over-year to -$53.4 million; the TTM figure through Sep 2023 stood at -$53.4 million (changed N/A YoY), while the FY2019 annual figure was $30.5 million, up 214.25% from the prior year.
• Acquisitions came in at -$53.4 million for Q4 2018 at Integra Lifesciences Holdings, down from $21.0 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $1.0 billion in Q4 2017 to a low of -$53.4 million in Q4 2018.
• Average Acquisitions over 5 years is $124.3 million, with a median of $20.6 million recorded in 2015.
• The largest YoY upside for Acquisitions was 225965.33% in 2017 against a maximum downside of 19300.0% in 2017.
• Over 5 years, Acquisitions stood at $85.9 million in 2014, then plunged by 75.99% to $20.6 million in 2015, then tumbled by 102.18% to -$450000.0 in 2016, then jumped by 225965.33% to $1.0 billion in 2017, then plunged by 105.25% to -$53.4 million in 2018.
• Per Business Quant data, the three most recent Acquisitions figures were -$53.4 million in Q4 2018, $21.0 million in Q2 2018, and $5.7 million in Q1 2018.